Clinical Trial: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421284) titled 'A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy' on Feb. 12.

Brief Summary: The purpose of this study is to compare the effectiveness, safety of SYH2053 in participants with primary hypercholesterolemia (non-familial) or mixed dyslipidemia on a background of lipid-lowering therapy.

This trial plans to enroll 900 Participants.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Intervention: DRUG: SYH2053/placebo injection ...